Treatment to stop sleeping sickness transmission
Part of Infections clinical trials.
This study tests a new oral treatment, acoziborole, for people with early-stage sleeping sickness (gambiense human African trypanosomiasis). It aims to see if the treatment can stop the disease from spreading in the community.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 11 years old or older and weigh at least 30 kg (about 66 pounds).
- You have tested positive for sleeping sickness using a rapid test or CATT test.
- You can swallow tablets.
- You are willing to use birth control if you could become pregnant.
- You are not pregnant or breastfeeding.
- You have not been treated for sleeping sickness before.
- You do not have jaundice (yellowing of skin or eyes).
- You are not taking certain medicines that could interfere with the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called acoziborole to see if it can stop the spread of sleeping sickness. If you've tested positive for the infection but don't have severe symptoms yet, this might help you get treated and prevent others from getting sick.
This study tests an oral medication, tafenoquine, to see if it helps people with chronic babesiosis who have ongoing fatigue and other symptoms. It aims to find a better treatment for this tick-borne infection that keeps coming back.
This study aims to find the best way to treat or prevent malaria in children with HIV. It may also help children without HIV who live in areas where malaria is common.
This study gives healthy volunteers a controlled infection with a type of malaria (vivax) to see how the infection behaves and how well curative anti-malaria medicine works. It may help researchers better design and test future malaria vaccines and treatments.
This trial looks at different ways to control mosquitoes that spread diseases. It will see how well these methods work in households and health facilities in Kinshasa.
This study tests a new investigational drug (GSK4425689A) for the first time in humans. It is a healthy volunteer study to check the safety, side effects, and how the drug moves through the body. It may help in the future development of treatments for malaria.
Hear when a new Human African Trypanosomiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.